Use of the blood substitute HBOC‐201 in critically ill patients during sickle crisis: a three‐case series

E-ISSN： 1537-2995|58|1|132-137

ISSN： 0041-1132

Source： TRANSFUSION, Vol.58, Iss.1, 2018-01, pp. : 132-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Levetiracetam use in critically ill patients

By Szaflarski Jerzy Meckler Jason Szaflarski Magdalena Shutter Lori Privitera Michael Yates Stephen

Neurocritical Care, Vol. 7, Iss. 2, 2007-10 ,pp. : 140-147

Humana Press, Inc

Access to resources Recommend Favorite

Comparison of three severity scores for critically ill cancer patients

By Schellongowski Peter Benesch Michael Lang Thomas Traunmüller Friederike Zauner Christian Laczika Klaus Locker Gottfried Frass Michael Staudinger Thomas

Intensive Care Medicine, Vol. 30, Iss. 3, 2004-03 ,pp. : 430-436

Springer Publishing Company

Access to resources Recommend Favorite

Clopidogrel in Critically Ill Patients

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 217-223

John Wiley & Sons Inc

Access to resources Recommend Favorite

What’s new in antimicrobial use and resistance in critically ill patients?

By Bassetti Matteo Nicolau David Calandra Thierry

Intensive Care Medicine, Vol. 40, Iss. 3, 2014-03 ,pp. : 422-426

Springer Publishing Company

Access to resources Recommend Favorite

Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 774-779

John Wiley & Sons Inc

Access to resources Recommend Favorite